Summary
The long-term goal of this research is to understand bone anabolism, cessation of treatment and fracture repair in the setting of Down Syndrome (DS). These studies will provide important new insights regarding the specific involvement of genes associated with trisomy 21 and the regulation of skeletal homeostasis. The application provides the first ever assessment of fracture repair and the impact of anabolic treatment cessation in DS.